Healthcare provider profile · identity verified

Lance T Hirano, MD

Infectious Disease · LONG BEACH, CA · NPI 1386751576

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	472	140
Amlodipine Besylate	Amlodipine Besylate	306	98
Losartan Potassium	Losartan Potassium	238	74
Hydrochlorothiazide	Hydrochlorothiazide	194	63
Tamsulosin Hcl	Tamsulosin Hcl	160	48
Levothyroxine Sodium	Levothyroxine Sodium	153	48
Metformin Hcl	Metformin Hcl	151	47
Omeprazole	Omeprazole	150	47
Rosuvastatin Calcium	Rosuvastatin Calcium	144	49
Gabapentin	Gabapentin	139	36
Pantoprazole Sodium	Pantoprazole Sodium	139	48
Lisinopril	Lisinopril	116	39
Albuterol Sulfate Hfa	Albuterol Sulfate	112	38
Metoprolol Succinate	Metoprolol Succinate	110	35
Zolpidem Tartrate	Zolpidem Tartrate	105	28
Montelukast Sodium	Montelukast Sodium	98	38
Jardiance	Empagliflozin	94	26
Methylprednisolone	Methylprednisolone	94	71
Simvastatin	Simvastatin	77	23
Diclofenac Sodium	Diclofenac Sodium	73	22
Trazodone Hcl	Trazodone Hcl	70	23
Metformin Hcl Er	Metformin Hcl	67	19
Pioglitazone Hcl	Pioglitazone Hcl	66	22
Potassium Chloride	Potassium Chloride	66	18
Eliquis	Apixaban	65	21
Alprazolam	Alprazolam	63	22
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	57	suppressed
Furosemide	Furosemide	56	18
Finasteride	Finasteride	55	15
Meloxicam	Meloxicam	55	16
Lorazepam	Lorazepam	54	18
Escitalopram Oxalate	Escitalopram Oxalate	51	19
Celecoxib	Celecoxib	50	14
Sildenafil Citrate	Sildenafil Citrate	49	11
Trulicity	Dulaglutide	49	suppressed
Azelastine Hcl	Azelastine Hcl	48	20
Fluticasone Propionate	Fluticasone Propionate	48	19
Ozempic	Semaglutide	48	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	47	21
Pravastatin Sodium	Pravastatin Sodium	45	14
Alendronate Sodium	Alendronate Sodium	44	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	17
Spironolactone	Spironolactone	43	12
Carvedilol	Carvedilol	42	13
Benazepril Hcl	Benazepril Hcl	41	13
Famotidine	Famotidine	40	14
Prednisone	Prednisone	40	15
Synthroid	Levothyroxine Sodium	40	11
Tradjenta	Linagliptin	40	suppressed
Tramadol Hcl	Tramadol Hcl	39	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	38	suppressed
Allopurinol	Allopurinol	37	13
Bupropion Xl	Bupropion Hcl	37	12
Clopidogrel	Clopidogrel Bisulfate	37	suppressed
Azithromycin	Azithromycin	36	29
Clonazepam	Clonazepam	36	suppressed
Propranolol Hcl	Propranolol Hcl	35	suppressed
Cefdinir	Cefdinir	34	27
Duloxetine Hcl	Duloxetine Hcl	33	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	11
Testosterone Cypionate	Testosterone Cypionate	33	suppressed
Ketoconazole	Ketoconazole	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	31	11
Ondansetron Hcl	Ondansetron Hcl	31	suppressed
Atenolol	Atenolol	30	11
Olmesartan Medoxomil	Olmesartan Medoxomil	30	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	30	12
Lovastatin	Lovastatin	28	suppressed
Meclizine Hcl	Meclizine Hcl	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	25	suppressed
Clobetasol Propionate	Clobetasol Propionate	25	suppressed
Nystatin	Nystatin	25	15
Donepezil Hcl	Donepezil Hcl	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Oxycodone Hcl	Oxycodone Hcl	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	13
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Dutasteride	Dutasteride	23	suppressed
Nitroglycerin	Nitroglycerin	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Fluconazole	Fluconazole	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	18
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Hydrocortisone	Hydrocortisone	20	11
Ibuprofen	Ibuprofen	20	suppressed
Mupirocin	Mupirocin	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	13
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Rizatriptan	Rizatriptan Benzoate	18	suppressed
Dulera	Mometasone/Formoterol	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Lubiprostone	Lubiprostone	17	suppressed
Naproxen	Naproxen	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Ramipril	Ramipril	17	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	16	suppressed
Testosterone	Testosterone	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	suppressed
Diazepam	Diazepam	15	suppressed
Estradiol	Estradiol	15	suppressed
Juluca	Dolutegravir/Rilpivirine	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Pimecrolimus	Pimecrolimus	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Baclofen	Baclofen	13	suppressed
Glipizide	Glipizide	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Levoxyl	Levothyroxine Sodium	13	suppressed
Valsartan	Valsartan	13	suppressed
Complera	Emtricita/Rilpivirine/Tenof Df	12	suppressed
Emtricitabine-Tenofovir Disop	Emtricitabine/Tenofovir (Tdf)	12	suppressed
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Lactulose	Lactulose	12	suppressed
Singulair	Montelukast Sodium	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Prolia	Denosumab	11	suppressed
Risperidone	Risperidone	11	suppressed
Scopolamine	Scopolamine	11	suppressed
Sumatriptan	Sumatriptan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error